170 related articles for article (PubMed ID: 30847274)
1. Recurrent intrathoracic dedifferentiated liposarcoma: A case report and literature review.
Ashraf U; Dudekula RA; Roy S; Burack J; Malik S; Khaja M
Respir Med Case Rep; 2019; 26():281-284. PubMed ID: 30847274
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
[TBL] [Abstract][Full Text] [Related]
3. Primary cardiac dedifferentiated liposarcoma in a middle-aged female: a case report.
Shen J; Fang Z; Zhang Y; Guo Y
J Cardiothorac Surg; 2019 Aug; 14(1):156. PubMed ID: 31470882
[TBL] [Abstract][Full Text] [Related]
4. A rare case of myxoid pleomorphic liposarcoma in an infant: A report.
Gami S; Tiwari SB; Gautam K; Sharma S; Shrivastav S; Sapkota R
Int J Surg Case Rep; 2021 Oct; 87():106365. PubMed ID: 34517205
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the understanding and management of liposarcoma.
Haddox CL; Riedel RF
Fac Rev; 2021; 10():1. PubMed ID: 33659920
[TBL] [Abstract][Full Text] [Related]
7. Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma.
Thirasastr P; Somaiah N
Ther Adv Med Oncol; 2022; 14():17588359221081073. PubMed ID: 35251319
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Features of Intrathoracic Liposarcoma-A Systematic Review with an Illustrative Case.
Kiełbowski K; Ruszel N; Skrzyniarz SA; Wojtyś ME; Becht R; Ptaszyński K; Gajić D; Wójcik J
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36555969
[TBL] [Abstract][Full Text] [Related]
9. Differences in recurrence and survival of extremity liposarcoma subtypes.
Vos M; Koseła-Paterczyk H; Rutkowski P; van Leenders GJLH; Normantowicz M; Lecyk A; Sleijfer S; Verhoef C; Grünhagen DJ
Eur J Surg Oncol; 2018 Sep; 44(9):1391-1397. PubMed ID: 29673808
[TBL] [Abstract][Full Text] [Related]
10. Influence of age and subtype in outcome of operable liposarcoma.
Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing of well-differentiated liposarcoma and dedifferentiated liposarcoma in older woman: a case report.
Zhao Z; Chen X; Xu J; Shi Y; Mak TK; Huo M; Zhang C
Front Med (Lausanne); 2023; 10():1237246. PubMed ID: 37649981
[TBL] [Abstract][Full Text] [Related]
12. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
13. Histology driven systemic therapy of liposarcoma-ready for prime time?
Grethlein SJ
Transl Gastroenterol Hepatol; 2018; 3():96. PubMed ID: 30603732
[TBL] [Abstract][Full Text] [Related]
14. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.
Muratori F; Frenos F; Bettini L; Matera D; Mondanelli N; Scorianz M; Cuomo P; Scoccianti G; Beltrami G; Greto D; Livi L; Baldi G; Roselli G; Capanna R; Campanacci DA
J Orthop Sci; 2018 Nov; 23(6):1038-1044. PubMed ID: 30007495
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Metastatic Dedifferentiated Liposarcoma Presenting as Hypereosinophilia in an Adolescent.
Balasubramanyam S; Hajjar J
J Immunother Precis Oncol; 2021 Feb; 4(1):21-25. PubMed ID: 35664823
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated liposarcoma primary to the chest wall with spontaneous shrinking: report of a case.
Itagaki Y; Fukunaga A; Takano H; Yamamoto K; Nishigami K; Ichimura T; Manase H; Obata M; Kato T; Hirano S
Surg Case Rep; 2023 Feb; 9(1):26. PubMed ID: 36788154
[TBL] [Abstract][Full Text] [Related]
18. An overview on liposarcoma subtypes: Genetic alterations and recent advances in therapeutic strategies.
M S A; K C; Bhargavan RV; Somanathan T; Subhadradevi L
J Mol Histol; 2024 Jun; 55(3):227-240. PubMed ID: 38696048
[TBL] [Abstract][Full Text] [Related]
19. Pseudocystic myxoid liposarcoma of the posterior chest wall - a rare case report.
Shakil S; Akhtar SE; Zaidi M; Ajmal R; Alsubai AK; Ramtohul R; Akbar A; Tabassi A; Tabassi A; Almas T
Ann Med Surg (Lond); 2023 Dec; 85(12):6252-6255. PubMed ID: 38098571
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of dedifferentiated liposarcoma in the extremities: A retrospective case series of 7 patients.
Kito M; Yoshimura Y; Isobe K; Aoki K; Suzuki S; Tanaka A; Okamoto M; Sano K; Kato H
J Orthop Sci; 2016 Sep; 21(5):673-7. PubMed ID: 27317086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
